Type 2 Diabetes Medications That Induce Weight Loss
Mar 22, 2024 · A weight loss of 5% to 15% can improve obesity-related complications. 1,2. There are approved medications to help treat obesity, including phentermine (Lomaira®), orlistat …
Oral and Transdermal Estrogen Dose Equivalents
Elestrin. Plant derived: Soy, Rapeseed, Pine tree wood. 1 pump (0.87g/d) = 0.0125mg estradiol. 2 pumps (1.7g/d) = 0.0375mg estradiol. Estrogel. Plant derived: Oil seed, Soy, Pine tree wood. …
Sellar Mass - Endocrinology Advisor
Sellar masses (SMs) are adenoma bodies that are typically located on or around the pituitary gland, specifically near the sella turcica. 1,2 Sellar masses are known to account for …
Gender-Affirming Surgery Rare Among Transgender Children in US
Aug 2, 2024 · The rate of gender-affirming surgery among TGD individuals was 5.3 per 100,000 adults, 2.1 per 100,000 adolescents aged 15 to 17 years, 0.1 per 100,000 adolescents aged …
SGLT2 Inhibitors - Endocrinology Advisor
Oct 9, 2024 · UGT = UDP-glucuronosyltransferase. From the FDA-approved prescribing information for each medication. 5-9 Warnings and Adverse Reactions. All SGLT2 inhibitors …
Acetaminophen Interference With Blood Glucose Readings: What …
Jun 12, 2017 · Clinicians managing blood glucose levels in critically ill children should take caution to ensure they are not treating false elevations of blood glucose caused by medication …
Long-Term Fatigue Is Common After Total Thyroidectomy
November 1, 2019. Approximately two-thirds of patients who undergo total thyroidectomy (TT) report new-onset fatigue within the first year after surgery, with only one-third reporting …
Hyperthyroidism and Thyrotoxicosis: Diagnosis and Management
Hyperthyroidism refers to increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis is characterized by the clinical manifestations of inappropriately …
Long-Term CGM System Eversense 365 Gets FDA Clearance
Sep 20, 2024 · The Food and Drug Administration (FDA) has cleared the Eversense 365 continuous glucose monitoring (CGM) system for patients aged 18 years and older with type 1 …
FDA Approves Xigduo XR for Type 2 Diabetes - Endocrinology …
Oct 31, 2014 · The FDA has approved once-daily Xigduo XR, a novel combination of dapagliflozin and metformin hydrochloride extended-release, to treat type 2 diabetes, according to a press …